Ifp Advisors, Inc Windtree Therapeutics Inc Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$0.14 - $6.9 $0 - $6	-1 Reduced 16.67%	5 $0
Q2 2022 Sep 06, 2022	BUY	$0.38 - $1.14 $2 - $6	6 New	6 $2,000
Q2 2022 Aug 12, 2022	SELL	$0.38 - $1.14 $2 - $6	-6 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$0.94 - $1.6 $0 - $1	1 Added 20.0%	6 $0
Q2 2020 Aug 05, 2020	BUY	$3.3 - $9.96 $16 - $49	5 New	5 $0

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $97.4M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.